| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 10,126,710 | 13,402,809 | ||
| Prepaid expenses and other current assets | 1,528,667 | 1,301,485 | ||
| Total current assets | 11,655,377 | 14,704,294 | ||
| Property and equipment, net | 15,293 | 16,179 | ||
| Right-of-use assets | 174,008 | 190,964 | ||
| Prepaid expenses, long-term | 18,743 | 19,125 | ||
| Goodwill | 12,209,591 | 12,458,383 | ||
| Intangible assets | 67,919,601 | 69,303,582 | ||
| Total assets | 91,992,613 | 96,692,527 | ||
| Accounts payable | 584,602 | 498,118 | ||
| Accrued expenses | 1,957,641 | 1,332,574 | ||
| Lease liability, current portion | 54,566 | 54,496 | ||
| Total current liabilities | 2,596,809 | 1,885,188 | ||
| Lease liability, long-term portion | 120,212 | 132,494 | ||
| Deferred tax liability | 11,890,483 | 12,134,222 | ||
| Total liabilities | 14,607,504 | 14,151,904 | ||
| Preferred stock-Preferred Stock Excluding Seriesa And Seriesa1Non Voting Convertible Preferred Stock | - | 0 | ||
| Series a non-voting convertible preferred stock, 0.0001 par value 2,104 shares authorized and 2,103.1494 shares issued and outstanding at september 30, 2025 and 2,270 shares authorized and 2,213.8044 shares issued and outstanding at december 31, 2024 | 70,126,957 | 75,662,024 | ||
| Common stock, 0.0001 par value 43,000,000 shares authorized 2,300,880 and 2,293,162 shares issued and outstanding at september 30, 2025, respectively and 1,339,896 and 1,332,178 shares issued and outstanding at december 31, 2024, respectively | 229 | 191 | ||
| Preferred stock-Seriesa Non Voting Convertible Preferred Stock | 5,535,067 | - | ||
| Preferred stock-Seriesa1Non Voting Convertible Preferred Stock | 24,994,461 | 24,994,461 | ||
| Preferred stock-Seriesa2Non Voting Convertible Preferred Stock | 9,800,839 | - | ||
| Additional paid-in capital | 73,158,686 | 71,001,615 | ||
| Accumulated deficit | -104,295,867 | -88,551,251 | ||
| Accumulated other comprehensive loss | -1,636,135 | -267,289 | ||
| Stockholders' equity before treasury stock | 7,557,280 | 7,177,727 | ||
| Less treasury stock, 7,718 shares of common stock at cost | 299,128 | 299,128 | ||
| Total stockholders' equity (deficit) | 7,258,152 | 6,878,599 | ||
| Total liabilities, series a non-voting convertible preferred stock and stockholders' equity (deficit) | 91,992,613 | 96,692,527 | ||
Dogwood Therapeutics, Inc. (DWTX)
Dogwood Therapeutics, Inc. (DWTX)